A Cytogenetic Survey of 8584 Children Referred for Suspected Congenital Disorders: The Experience of a Children's Hospital in China from 1996 to 2010
Objectives: We evaluated the type and incidence of different chromosomal abnormalities among paediatric patients presented with congenital abnormalities in a paediatric hospital over the past 15 years. Material and methods: Peripheral blood lymphocytes were obtained from 8584 paediatric patients with suspected chromosomal aberrations in the Children's Hospital of Zhejiang University School from 1996 to 2010. Their age were between 0 and 18 years. Cytogenetic analysis was performed by G-banding technique. The cases were grouped according to the reasons of referral for cytogenetic analysis. The frequency of various abnormal karyotypes was analysed. Results: The main indications for cytogenetic analysis were congenital genitourinary defect, which accounted for 39.6% (3402/8584). The referrals of congenital genitourinary defects group increased while other groups decreased during 2006-2010 compared to 1996-2000. Abnormal karyotypes were found in 24.4% (2094/8584) and 77.0% (1612/2094) had autosomal abnormalities. Among them, trisomy 21 was the most frequent one. The remaining 23.0% (482/2094) were sex chromosome abnormalities, 199 cases were structural abnormalities and 283 cases were numerical abnormalities. The ratio of autosomal abnormalities to sex chromosome abnormalities showed a decrease trend. Turner syndrome accounted for 12.7% (265/2094) of abnormal karyotypes. Eighty nine cases of XY female (46,XY complete gonadal dysgenesis) and 58 cases of XX male (46,XX testicular disorder of sexual development) were diagnosed, which consisted of 7.0% (147/2094) in all chromosomal anomalies. Conclusions: The incidence and distribution of cytogenetic abnormalities by karyotype were reviewed. The high rate of chromosomal abnormalities (24.4%) found in our referred population demonstrates the importance of cytogenetic evaluation in patients who are clinically abnormal. The main clinical indications for genetic analysis were congenital genitourinary defects, the ratio between sex chromosome abnormality and autosomal abnormality elevated with the increase of cases referral for congenital genitourinary defects. This is due to referral bias of a paediatric medical center with developed paediatric urology subspecialty. Our data may help in providing some correlation data for genetic counselling on this aspect.
Keyword : Abnormal karyotypes; Children; Cytogenetic testing; Disorders of sex development; Monosomy
Genetic factors have long been recognised to be an important cause for syndromal and nonsyndromal congenital anomalies. Previous cytogenetic investigations demonstrated that constitutional chromosomal abnormalities affect about 0.5% of live-born infants and contribute to a significant proportion of birth defects. Congenital anomalies are also one of the leading causes of neonatal morbidity and mortality in many countries.1,2 Common chromosomal abnormalities have traditionally been diagnosed during the neonatal period by conventional cytogenetic methods such as trypsin-Giemsa staining (GTG banding) analysis.3 Despite advances in prenatal diagnosis and perinatal management, congenital anomalies still remain a major cause of neonatal morbidity and mortality, and most of the underlying genetic causes remain unknown.
Precise diagnosis for the child's pattern of congenital anomalies is critical because it may guide the subsequent medical and surgical management as well as helping to provide accurate information to families regarding the prognosis and recurrence risks. During the last decades, study of fetal karyotypes has become a very important tool for genetic counselling on the recurrence risk and/or pregnancies at risk. Even though prenatal diagnosis is gaining popular recently, there are still some children who haven't been detected before birth. This group of patients with chromosomal abnormalities identified after birth still remain an important problem and many of their structural abnormalities requires early intervention. It is therefore necessary to provide diagnosis as soon as possible.
The Children's Hospital of Zhejiang University School of Medicine is the largest paediatric referral center of Zhejiang province, serving approximately 8 million children below the age of 18 years. The present study was aimed to investigate the frequency of different chromosomal abnormalities in patients referred for cytogenetic analyses a from 1996 to 2010. This study is the first report on this particular topic from the Southeast region of China. We hope our study can raise the awareness of clinicians (especially paediatricians) on the cytogenetic abnormalities so they can offer proper genetic counselling.
Subjects and Methods
All samples for cytogenetic analyses were analysed in the Medical Biology and Genetic Department Laboratory at the Children's Hospital of Zhejiang University School of Medicine. The informed consents were obtained from children's parent/guardian or other legally authorised representative if necessary (hereafter referred to as the legally authorised representatives). A detailed interview was conducted before cytogenetic analysis with medical history obtained. Patients presented with congenital anomalies, intellectual disability, short stature and other miscellaneous defects were included in the study. According to the reason for referral for cytogenetic study, we divided them into four groups: 1) group suspected for Down's syndrome (Down's syndrome group), who presented with a specific clinical stigmata (such as up slanting palpebral fissure, prominent epicantic folds, micrognathia, etc.); 2) group suspected for Turner syndrome (Turner syndrome group) who presented with short stature and characteristic physical phenotypes (such as low hairline, webbed neck, down slanting eyes, shield chest), primary amenorrhea, delayed puberty, absence of ovaries, etc.; 3) congenital genitourinary defects group (including ambiguous genitalia, abnormality of male external genitalia, concealed penis, cryptorchidism, etc); and 4) miscellaneous group (including intellectual disability, developmental delay, obesity, congenital heart diseases and other indications not listed in the above three group).
Sex in mammals is genetically determined and defined at the cellular level by sex chromosome complement (XY males and XX females) and defined at the phenotypic level by the development of gender-specific anatomy, physiology, and behavior. Disorders of sex development (DSD) in humans are characterised by a complete or partial mismatch between genetic sex and phenotypic sex. Combined with medical genetics, ultrasound diagnostics, hormonal profile and pathology, DSD can be diagnosed.
For routine cytogenetic analysis, 0.5-1.0 mL peripheral blood samples were collected from the patients and stored into heparinized test tubes. They were cultured in complete lymphocyte culture medium within an incubator at 37oC for 72 hours. Metaphases were harvested by adding colcemid for 60 minutes followed by hypotonic KCl treatment for 5 minutes and fixation using standard 3:1 methanol-acetic fixative (Gibco Life Technologies Ltd, UK). The karyotypes were determined by G-banding using trypsin and Giemsa (GTG) (Seabright, 1971) and C-banding using barium (Sumner, 1972) as well as Giemsa (CBG) (Salamanca and Armendares, 1974) when necessary. At least 30 cells were routinely analysed; in cases of mosaicism, this number was increased to approximately 100 metaphases. In our hospital, there isn't any change of laboratory protocol or personnel in the Genetic Department Laboratory in the past 18 years. The karyotypic descriptions were reported according to the International System for Human Cytogenetic Nomenclature recommendations (ISCN, 1995).
The percentage of abnormal cases in each group and the distribution of the numerical and structural abnormalities were determined. The frequencies were compared to similar studies using the Z-test for comparison of two frequencies with unequal variance.
There were 8584 patients less than 18 years old referred for cytogenetic analyses from 1st January 1996 to 31st December 2010. Among them, 6047 were male and 2537 were female, the ratio of male to female was 2.38:1. The number of samples gradually increased from 1996 to 2010, which were 193 cases in 1996 and increased to 1115 cases in 2010 respectively. The ratio between cases referred for cytogenetic analyses and outpatient visits also increased in the past fifteen years, which was 1:2899 (193/559569) in 1996, 1:2227 (374/832970) in 2001, 1:1686 (669/1134914) in 2006 and 1:1371 (1115/1530332) in 2010 respectively. The ratio of males to females in the cases of cytogenetic survey increased gradually from 1996 to 2010, which were 1.7:1 (122/71) in 1996, 1.9:1 (245/129) in 2001, 2.4:1 (475/194) in 2006 and 4:1 (892/223) in 2010 respectively. The ratio of cases ≤1 years versus the cases more than 1-year- old for cytogenetic analysis showed an decreasing trend too, which was 1:1.3 in 1996, 1:1.1 in 2001, 1:1.5 in 2006, and 1:2.2 in 2010.
The main clinical indications for genetic analysis were congenital genitourinary defects, which accounted for 39.6% (3402/8584) of the total cases referred for examination in the past 15 years. The next most common referrals were miscellaneous group, which accounted for 30.4% (2611/8584) (Table 1). The percentage of cases suspected for Down's syndrome and miscellaneous group decreased gradually, which was 28.5% (55/193) and 52.8% (102/193) in 1996, 26.5% (99/374) and 41.4% (155/374) in 2001, 15.7% (105/669) and 29.1% (195/669) in 2006, 10.6% (118/1115) and 20.0% (223/1115) in 2010 respectively. The percentage of cases suspected for Turner Syndrome group ranged from 4.7% in 1997 to 18.5% in 2009. The percentage of cases presented with congenital genitourinary defects increased significantly, which was 8.3% (16/193) in 1996, 22.2% (83/374) in 2001, 39.1% (262/669) in 2001 and 58.4% (651/1115) in 2010 respectively. The referrals of congenital genitourinary defects group increased while miscellaneous group and Down syndrome group decreased during 2006-2010 period compared with 1996-2000 period (Table 2).
Abnormal chromosomes were found in 24.4% (2094/8584) of the cases. The number of abnormal karyotypes showed a gradual increase, which was 70 cases in 1996, 117 cases in 2001, 167 cases in 2006 and 190 cases in 2010. However, the detected incidence of abnormal karyotype each year decreased substantially, which was 36.3% in 1996, 31.3% in 2001, 25.0% in 2006 and 15.8% in 2010 respectively. Of these abnormal karyotypes, 77.0% (1612/2094) consisted of classical autosomal abnormalities; the remaining 23.0% (482/2094) were sex chromosome abnormalities (Table 3). The ratio of autosomal abnormalities to sex chromosome abnormalities showed a decreasing trend, which was 15.5:1 in 1996 and 2.1:1 in 2010. Compared through 5-year periods, the percentage of sex chromosome abnormalities during 2006-2010 was higher than that during the 1996-2000 period (29.3% vs.14.4%, p=0.000) (Figure 1).
We further investigated the 1612 cases of autosomal abnormities. Down syndrome was the most frequent one (93%, 1499/2094). Of all Down syndrome cases, 1392 cases (92.9%, 1392/1499) had classical trisomy 21 and 107 cases (7.1%, 107/1499) had a translocation, mostly Robertsonian t (14;21) and t (21;21) or were mosaics. The overall sex ratio in Down syndrome increased as well (male to female: 1.82 to 1). One hundred and twelve cases (6.9%) had other types of autochrosome abnormities including trisomy 18, trisomy 13, 46,XX,r(14), 46,XY,5p, and others (Table 4).
Among 482 cases of sex chromosome abnormalities, 199 cases were structural abnormalities and 283 cases were numerical abnormalities. Turner syndrome accounted for 12.7% (265/2094) of abnormal karyotypes, of which, 113 cases had X monosomies. Of the 199 cases with structural abnormalities in sex chromosome, combined with medical genetics, clinic indications and ultrasound diagnostics, hormonal measurements and pathology, 89 cases of XY female (XY sex reversal or 46,XY complete gonadal dysgenesis) and 58 cases of XX male (XX sex reversal or 46, XX testicular DSD) were diagnosed in our cohort, which consisted of 7.0% (147/2094) in all chromosome anomalies. There were wide variations in sex chromosome trisomies (SCTs),XYY XXX /XX, r(X), and XXY accounted for 1, 9 and 28 cases respectively. Other sex chromosome trisomy karyotypes were mosaic, including 45,X/47,XXX, 45,X/47,XYY, 45,X/46,XY/47,XYY, 46,XY/47,XXY 46,XY/47,XYY 48,XYY,+21 and 48,XXY,+21. The remaining different forms of abnormal sexual karyotypes are shown in Table 5.
1. The Detection Rate
The last decades has witnessed the significant improvement in the health status and disease profile in China. The major causes of death and disability have shifted from a predominance of nutritional deficiencies and infectious diseases to chronic non-communicable diseases. This transition occurs not only among different disease categories, but also within a specific disease category.4 The ratio between cases referred for cytogenetic analyses and outpatient visits increased in the past fifteen years in our hospital-based study. It partly demonstrated the changes of disease profiles and case mix in our hospital, which meant more patients suspected for congenital anomalies or genetic disorders are coming to our hospital. Zhang et al analysed the karyotype of 4,046 cases aged from 1 day to 17 years old in the Children's Hospital of Fudan University during January 1990 to December 2006, there were 660 (16.3%) cases with abnormal chromosome karyotypes.5 Li et al investigated 4628 children aged from 1 day to 18 years old in the Children s Hospital of Chongqing Medical University from January 1982 to December 2006, a total of 22.67% (1049/4628) patients were identified to have abnormalities.6 Abnormal chromosomes were found in 24.4% (2094/8584) of our cases, The detection rate in our hospital was a little higher than the reports from other children's hospitals. However, the detection rate and chromosome malformation profiles from paediatric hospital are different from that of Chinese general population.7 However, the number of abnormal karyotype detected annually decreased substantially from 36.3% in 1996 to 15.8% in 2010 respectively. Chromosomal analysis is applicable only for patients with a strong clinical suspicion of a specific genetic defect. This is often challenging in children with non-stereotypic or syndromal genetic disorders, because their clinical presentations may not be evident yet or may be atypical. They may also lack specific syndromic features initially and evolve only at a later age. The significant decrease of the detection rate may also be due to less stringent referral criteria because each paediatrician can request a chromosomal analysis in our hospital without restriction.
2. Clinical Indications for Referral
3. Abnormal Karyotypes
Of all Down syndrome cases, 1392 cases (92.9%, 1392/1499) had classical trisomy 21. Classical trisomy 21 was present in 96.24% in a Moroccan population.10 Among the 5737 cases registered in England and Wales between 1989 and 1993, 95% had classical trisomy 21. In 4% there was a translocation.11 The profiles of Down syndrome in our hospital were similar to the previous studies. A strong trend towards an association between the cosmic ray activity level and the incidence of Down syndrome had been reported in Israel.12 A well designed questionnaire including clinical and laboratory data collected prospectively is necessary for studying of the etiology and phenotypic consequences of Down syndrome. Though regional sample may not represent the characteristic of the general population in terms of the prevalence of specific congenital anomalies, this study may provide useful information in phenotype correlation with cytogenetic profiles.
4. Sex Chromosome Anomalies
5. Double Aneuploidies (DAs)
Limitations of this study include that patients with congenital defects were not characterised on the basis of their congenital defects due to limited clinical information available. In addition, the data are derived from a single clinical service and therefore cannot represent the general population. Thirdly, the unavailability of chromosomal microarray analysis (CMA) or microarray-based comparative genomic hybridization (aCGH) may lead to the under-detection of some cryptic cytogenetic conditions like chromosome 22q11.2 deletion, Prader-Willi syndrome and SRY microdeletion in the present survey.20 Array CGH or CMA will increase the detection rate and enable the clinical diagnosis of chromosomal abnormalities at a much higher resolution.
In conclusion, this is one of the largest cohorts of cytogenetic testing in paediatric population from a single paediatric medical center. The high rate of chromosomal abnormalities (24.4%) found in our referred population demonstrates the importance of cytogenetic evaluation in patients who are clinically abnormal. The main clinical indications for genetic analysis were congenital genitourinary defects. The ratio between sex chromosome abnormality and autosomal chromosomal abnormality showed an increasing trend with the increase of referral for congenital genitourinary defects in the recent years. This study provides useful information for clinical genetic counselling.
This work was supported by Key Science and Technology Innovation Team of Zhejiang Province (2010R50045). The authors hereby declare that there is no conflict of interest that would prejudice the impartiality of this scientific work.
1. Dolk H, Loane M, Garne E. The prevalence of congenital anomalies in Europe. Adv Exp Med Biol 2010;686:349-64.
2. Boghossian NS, Hansen NI, Bell EF, et al. Survival and morbidity outcomes for very low birth weight infants with Down syndrome. Pediatrics 2010;126:1132-40.
3. Ocal G, Berberolu M, Siklar Z, et al. Disorders of sexual development: an overview of 18 years experience in the pediatric Endocrinology Department of Ankara University. J Pediatr Endocrinol Metab 2010;23:1123-32.
4. Yang G, Kong L, Zhao W, et al. Emergence of chronic non-communicable diseases in China. Lancet 2008;372:1697-705.
5. Zhang J, Huang G, Ni Z, et al. Retrospective analysis of the relationship between the outcomes of chromosome examination and congenital heart disease in 4046 cases. Chin J Evid Based Pediatr 2009;4:128-34.
6. Li C, Cheng X, Zhang W. Cytogenetic analysis and its significance of 4628 children for genetic counseling in Chongqing. J Chongqing Med Univ 2008;33:720-3.
7. Hu YL; Birth Defect Intervention Group of Jiangsu Province. Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26,803 pregnant women in Jiangsu Province. Zhonghua Yi Xue Za Zhi 2007;87:2476-80.
8. Lu Y, Li Y, lu TT. Birth Defects from 13 Midwifery Institution During the Year of 2006-2009 in Wuchang Region. Chinese J Obstet Gynecol Pediatr 2011;7:117-20.
9. Freeman SB, Allen EG, Oxford-Wright CL, et al.The National Down Syndrome Project: design and implementation. Public Health Rep 2007;122:62-72.
10. Yang JH, Kim YJ, Chung JH, et al. A multi-center study for birth defect monitoring systems in Korea. J Korean Med Sci 2004;19:509-13.
11. Mahfouz R, al-Oreibi G, Darwiche N, el-Khechen S, Zahed L. Constitutional chromosome abnormalities among patients referred for blood karyotype analysis: a 5-year study at the AUBMC. J Med Liban 2001;49:6-12.
12. Stoupel EG, Frimer H, Appelman Z, et al.Chromosome aberration and environmental physical activity: Down syndrome and solar and cosmic ray activity, Israel, 1990-2000. Int J Biometeorol 2005;50:1-5.
13. Rankin J, Pattenden S, Abramsky L, et al. Prevalence of congenital anomalies in five British regions, 1991-99. Arch Dis Child Fetal Neonatal Ed 2005;90:F374-9.
14. Balkan M, Akbas H, Isi H, et al. Cytogenetic analysis of 4216 patients referred for suspected chromosomal abnormalities in Southeast Turkey. Genet Mol Res 2010;9:1094-103.
15. Sutton E, Hughes J, White S, et al. Identification of SOX3 as an XX male sex reversal gene in mice and humans. J Clin Invest 2011;121:328-41.
16. Boyd PA, Loane M, Garne E, Khoshnood B, Dolk H; EUROCAT working group. Sex chromosome trisomies in Europe: prevalence, prenatal detection and outcome of pregnancy. Eur J Hum Genet 2011;19:231-4.
17. Temel SG, Gulten T, Yakut T, et al. Extended pedigree with multiple cases of XX sex reversal in the absence of SRY and of a mutation at the SOX9 locus. Sex Dev 2007;1:24-34.
18. Waters PD, Wallis MC, Marshall Graves JA. Mammalian sex-origin and evolution of the Y chromosome and SRY. Semin Cell Dev Biol 2007;18:389-400.
19. Kovaleva NV, Mutton DE. Epidemiology of double aneuploidies involving chromosome 21 and the sex chromosomes. Am J Med Genet A 2005;134A:24-32.
20. Lu XY, Phung MT, Shaw CA, et al. Genomic imbalances in neonates with birth defects: high detection rates by using chromosomal microarray analysis. Pediatrics 2008;122:1310-8.
This web site is sponsored by Johnson & Johnson (HK) Ltd.